Xponance, Inc. Charles River Laboratories International, Inc. Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 7,269 shares of CRL stock, worth $1.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,269

Previous 7,043 3.21%

Holding current value

$1.36 Million

Previous $1.45 Million 1.58%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$187.96 - $245.29 $42,478 - $55,435	226 Added 3.21%	7,269 $1.43 Million
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $26,830 - $34,934	-130 Reduced 1.81%	7,043 $1.45 Million
Q1 2024 May 13, 2024	BUY	$203.52 - $273.43 $87,106 - $117,028	428 Added 6.35%	7,173 $1.94 Million
Q4 2023 Jan 31, 2024	SELL	$164.52 - $238.84 $105,950 - $153,812	-644 Reduced 8.72%	6,745 $1.59 Million
Q3 2023 Oct 23, 2023	BUY	$194.44 - $217.61 $65,137 - $72,899	335 Added 4.75%	7,389 $1.45 Million
Q2 2023 Jul 13, 2023	SELL	$183.71 - $210.25 $883,828 - $1.01 Million	-4,811 Reduced 40.55%	7,054 $1.48 Million
Q1 2023 Apr 17, 2023	BUY	$191.89 - $259.92 $8,059 - $10,916	42 Added 0.36%	11,865 $2.39 Million
Q4 2022 Jan 23, 2023	BUY	$197.11 - $250.07 $202,431 - $256,821	1,027 Added 9.51%	11,823 $0
Q3 2022 Oct 24, 2022	BUY	$182.44 - $250.54 $186,271 - $255,801	1,021 Added 10.45%	10,796 $2.13 Million
Q2 2022 Aug 02, 2022	BUY	$204.13 - $302.4 $309,461 - $458,438	1,516 Added 18.36%	9,775 $2.09 Million
Q1 2022 Apr 20, 2022	BUY	$255.51 - $362.11 $26,828 - $38,021	105 Added 1.29%	8,259 $2.35 Million
Q4 2021 Jan 31, 2022	BUY	$351.38 - $448.68 $284,969 - $363,879	811 Added 11.04%	8,154 $3.07 Million
Q3 2021 Nov 05, 2021	SELL	$372.64 - $458.3 $68,565 - $84,327	-184 Reduced 2.44%	7,343 $3.03 Million
Q2 2021 Aug 12, 2021	SELL	$294.17 - $371.65 $655,704 - $828,407	-2,229 Reduced 22.85%	7,527 $2.78 Million
Q1 2021 May 10, 2021	BUY	$249.67 - $299.48 $12,982 - $15,572	52 Added 0.54%	9,756 $2.83 Million
Q4 2020 Feb 11, 2021	BUY	$222.0 - $252.62 $2,886 - $3,284	13 Added 0.13%	9,704 $2.43 Million
Q3 2020 Oct 26, 2020	BUY	$175.56 - $226.45 $134,127 - $173,007	764 Added 8.56%	9,691 $2.2 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $1.06 Million - $1.69 Million	8,927 New	8,927 $1.56 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.49B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account